These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7537801)

  • 21. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
    Caty A; Depadt G; Feutry ML
    Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperitoneal metastasis--clinical implications.
    Otto T; Virchow S; Fuhrmann C; Steinberg F; Streffer C; Goepel M; Rübben H
    Urol Res; 1997; 25(2):121-4. PubMed ID: 9144879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
    Albers P; Weissbach L; Krege S; Kliesch S; Hartmann M; Heidenreich A; Walz P; Kuczyk M; Fimmers R;
    J Urol; 2004 May; 171(5):1835-8. PubMed ID: 15076288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcome of retroperitoneal lymph node dissection after induction chemotherapy for metastatic non-seminomatous germ cell tumors.
    Muramaki M; Hara I; Miyake H; Yamada Y; Okada H; Kamidono S
    Int J Urol; 2004 Sep; 11(9):763-7. PubMed ID: 15379941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation.
    Jaeger N; Weissbach L; Bussar-Maatz R
    World J Urol; 1994; 12(4):196-9. PubMed ID: 7820141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB; Nichols CR; Foster RS; Messemer JE; Donohue JP; Einhorn LH
    J Urol; 1996 Feb; 155(2):587-9. PubMed ID: 8558665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
    J Clin Oncol; 1997 Feb; 15(2):594-603. PubMed ID: 9053482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testis.
    Brenner PC; Herr HW; Morse MJ; Sheinfeld J; Aprikian A; Bosl GJ; Motzer RJ; Bajorin DF; Schantz S; Fair WR; Burt M
    J Clin Oncol; 1996 Jun; 14(6):1765-9. PubMed ID: 8656244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies.
    Sheinfeld J
    Semin Urol Oncol; 2002 Nov; 20(4):262-71. PubMed ID: 12489059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ; Norman AR; Dearnaley DP; Horwich A
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling.
    Kollmannsberger C; Nichols C; Meisner C; Mayer F; Kanz L; Bokemeyer C
    Ann Oncol; 2000 Sep; 11(9):1115-20. PubMed ID: 11061604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
    Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
    Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
    J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
    Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
    Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
    Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
    J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.